Targeting high glucose-induced epigenetic modifications at cardiac level: the role of SGLT2 and SGLT2 inhibitors

to related objects

Location
Deutsche Nationalbibliothek Frankfurt am Main
ISSN
1475-2840
Extent
Online-Ressource
Language
Englisch
Notes
online resource.

Bibliographic citation
Targeting high glucose-induced epigenetic modifications at cardiac level: the role of SGLT2 and SGLT2 inhibitors ; volume:22 ; number:1 ; day:2 ; month:2 ; year:2023 ; pages:1-14 ; date:12.2023
Cardiovascular diabetology ; 22, Heft 1 (2.2.2023), 1-14, 12.2023

Creator
Scisciola, Lucia
Taktaz, Fatemeh
Fontanella, Rosaria Anna
Pesapane, Ada
Surina
Cataldo, Vittoria
Ghosh, Puja
Franzese, Martina
Puocci, Armando
Paolisso, Pasquale
Rafaniello, Concetta
Marfella, Raffaele
Rizzo, Maria Rosaria
Barbato, Emanuele
Vanderheyden, Marc
Barbieri, Michelangela
Contributor
SpringerLink (Online service)

DOI
10.1186/s12933-023-01754-2
URN
urn:nbn:de:101:1-2023040721045977636657
Rights
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Last update
14.08.2025, 10:50 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Show original at data provider

Associated

  • Scisciola, Lucia
  • Taktaz, Fatemeh
  • Fontanella, Rosaria Anna
  • Pesapane, Ada
  • Surina
  • Cataldo, Vittoria
  • Ghosh, Puja
  • Franzese, Martina
  • Puocci, Armando
  • Paolisso, Pasquale
  • Rafaniello, Concetta
  • Marfella, Raffaele
  • Rizzo, Maria Rosaria
  • Barbato, Emanuele
  • Vanderheyden, Marc
  • Barbieri, Michelangela
  • SpringerLink (Online service)

Other Objects (12)

SGLT2 and cancer

SGLT2 and cancer

A Fluorescent Glucose Transport Assay for Screening SGLT2 Inhibitors in Endogenous SGLT2-Expressing HK-2 Cells

A Fluorescent Glucose Transport Assay for Screening SGLT2 Inhibitors in Endogenous SGLT2-Expressing HK-2 Cells

Physiology of renal glucose handling via SGLT1, SGLT2 and GLUT2

Physiology of renal glucose handling via SGLT1, SGLT2 and GLUT2

Amelioration of diabetic nephropathy by SGLT2 inhibitors independent of its glucose-lowering effect: A possible role of SGLT2 in mesangial cells

Amelioration of diabetic nephropathy by SGLT2 inhibitors independent of its glucose-lowering effect: A possible role of SGLT2 in mesangial cells

Insulin stimulates SGLT2-mediated tubular glucose absorption via oxidative stress generation

Insulin stimulates SGLT2-mediated tubular glucose absorption via oxidative stress generation

Transport and inhibition mechanism of the human SGLT2–MAP17 glucose transporter

Transport and inhibition mechanism of the human SGLT2–MAP17 glucose transporter

SGLT2-Hemmer : Geringere Mortalität und Nierenschutz

SGLT2-Hemmer : Geringere Mortalität und Nierenschutz

Direct cardiac effects of SGLT2 inhibitors

Direct cardiac effects of SGLT2 inhibitors

Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors and Cardiovascular Disease: A Systematic Review

Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors and Cardiovascular Disease: A Systematic Review

Sodium-Glucose Cotransporter 2 (SGLT2) Inhibition in Kidney Transplant Recipients with Diabetes Mellitus

Sodium-Glucose Cotransporter 2 (SGLT2) Inhibition in Kidney Transplant Recipients with Diabetes Mellitus

Sodium-Glucose Cotransporter 2 (SGLT2) Inhibition in Kidney Transplant Recipients with Diabetes Mellitus

Sodium-Glucose Cotransporter 2 (SGLT2) Inhibition in Kidney Transplant Recipients with Diabetes Mellitus

SGLT2-Inhibitoren – Effektive Blutzuckerregulation über die Niere

SGLT2-Inhibitoren – Effektive Blutzuckerregulation über die Niere

Related objects